169 related articles for article (PubMed ID: 37661506)
1. [Radiation-induced lymphopenia: Lymphocytes as a new organ at risk].
Laurent PA; Deutsch É
Cancer Radiother; 2023 Sep; 27(6-7):511-518. PubMed ID: 37661506
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of radiation-induced lymphopenia and therapeutic impact].
Cesaire M; Le Mauff B; Rambeau A; Toutirais O; Thariat J
Bull Cancer; 2020; 107(7-8):813-822. PubMed ID: 32451070
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy and radiotherapy - a future partnership Focus on radiation induced lymphopenia (RIL) implications.
Mirestean CC; Iancu RI; Iancu DT
Bratisl Lek Listy; 2023; 124(1):70-73. PubMed ID: 36519611
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model.
Telarovic I; Yong CSM; Guckenberger M; Unkelbach J; Pruschy M
Neoplasia; 2022 Sep; 31():100812. PubMed ID: 35667149
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy.
Lambin P; Lieverse RIY; Eckert F; Marcus D; Oberije C; van der Wiel AMA; Guha C; Dubois LJ; Deasy JO
Semin Radiat Oncol; 2020 Apr; 30(2):187-193. PubMed ID: 32381298
[TBL] [Abstract][Full Text] [Related]
6. Kaplan lecture 2023: lymphopenia in particle therapy.
Durante M
Int J Radiat Biol; 2024; 100(5):669-677. PubMed ID: 38442137
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors.
Venkatesulu BP; Mallick S; Lin SH; Krishnan S
Crit Rev Oncol Hematol; 2018 Mar; 123():42-51. PubMed ID: 29482778
[TBL] [Abstract][Full Text] [Related]
8. Radiation induced lymphopenia - a possible critical factor in current oncological treatment.
Kubeš J; Dědečková K; Abass FAS; Vondráček V
Klin Onkol; 2023; 36(1):6-11. PubMed ID: 36868828
[TBL] [Abstract][Full Text] [Related]
9. A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy.
Wang X; Wang P; Zhao Z; Mao Q; Yu J; Li M
Ther Adv Med Oncol; 2020; 12():1758835920926822. PubMed ID: 32518598
[TBL] [Abstract][Full Text] [Related]
10. A framework for modeling radiation induced lymphopenia in radiotherapy.
Jin JY; Mereniuk T; Yalamanchali A; Wang W; Machtay M; Spring Kong FM; Ellsworth S
Radiother Oncol; 2020 Mar; 144():105-113. PubMed ID: 31794944
[TBL] [Abstract][Full Text] [Related]
11. Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers.
Césaire M; Rambeau A; Cherifi F; Géry B; Johnson A; Nacher M; Thariat J
Cancer Radiother; 2023 Apr; 27(2):145-153. PubMed ID: 36759240
[TBL] [Abstract][Full Text] [Related]
12. Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy.
Koukourakis MI; Giatromanolaki A
Crit Rev Oncol Hematol; 2021 Mar; 159():103226. PubMed ID: 33482348
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy.
Venkatesulu B; Giridhar P; Pujari L; Chou B; Lee JH; Block AM; Upadhyay R; Welsh JS; Harkenrider MM; Krishnan S; Verma V; En Hsieh C; Pradhan S; Small W; Solanki AA
Radiother Oncol; 2022 Dec; 177():81-94. PubMed ID: 36334694
[TBL] [Abstract][Full Text] [Related]
14. FLASH radiotherapy sparing effect on the circulating lymphocytes in pencil beam scanning proton therapy: impact of hypofractionation and dose rate.
Galts A; Hammi A
Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38081067
[No Abstract] [Full Text] [Related]
15. Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort.
Byun HK; Chung SY; Kim KJ; Seong J
Cancer Res Treat; 2021 Oct; 53(4):962-972. PubMed ID: 33540496
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy.
Kleinberg L; Sloan L; Grossman S; Lim M
Neurosurgery; 2019 Oct; 85(4):441-453. PubMed ID: 31232425
[TBL] [Abstract][Full Text] [Related]
17. A review on lymphocyte radiosensitivity and its impact on radiotherapy.
Paganetti H
Front Oncol; 2023; 13():1201500. PubMed ID: 37601664
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review.
Kut C; Kleinberg L
Chin Clin Oncol; 2023 Feb; 12(1):4. PubMed ID: 36922353
[TBL] [Abstract][Full Text] [Related]
19. Radio-induced lymphopenia in the era of anti-cancer immunotherapy.
de Kermenguy F; Meziani L; Mondini M; Clémenson C; Morel D; Deutsch E; Robert C
Int Rev Cell Mol Biol; 2023; 378():1-30. PubMed ID: 37438014
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients.
Stratton JA; Byfield PE; Byfield JE; Small RC; Benfield J; Pilch Y
J Clin Invest; 1975 Jul; 56(1):88-97. PubMed ID: 1095613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
